Navigation Links
Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
Date:12/15/2008

BOSTON, Dec. 15 /PRNewswire/ -- Rcadia Medical Imaging, Ltd., developer of the COR Analyzer(TM) software for the automated analysis of coronary CT angiography (CCTA) studies, has closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA, Rcadia announced today. Existing investors, including 20/20 HealthCare Partners, also participated in the financing.

Developed by leading Israeli image processing scientists, the COR Analyzer(TM) enables rapid and effective triage of chest pain patients. Immediately after a Coronary CTA study, the COR Analayzer(TM) identifies patients who need further evaluation for severe coronary artery disease, versus those who can be safely discharged. While improving emergency department (ED) workflow, the Rcadia application also can lead to more rapid diagnosis, enabling appropriate treatments and avoiding unnecessary delays for patients without coronary artery disease.

Shai Levanon, Rcadia President and CEO, said that the proceeds of the financing will fund the full commercial launch of the COR Analyzer(TM) and the establishment of a U.S. office to support North American sales and marketing.

"We are extremely pleased to be partnering with BioVentures Investors in this financing round," commented Hillel Bachrach, Executive Chairman of the Board of Directors and Managing Partner at 20/20 HealthCare Partners. "BioVentures has unique expertise in the commercial development of advanced technology in the life sciences." (www.bioventuresinvestors.com)

Simultaneous with the financing, Peter Feinstein, General Partner, BioVentures Investors, and Alex Norbash, M.D., Chairman of Radiology, Boston University Medical Campus, have joined Rcadia's board of directors.

About Rcadia Medical Imaging

Rcadia Medical Imaging is the principal developer of automatic image processing software products for blood vessel analysis. The company's FDA cleared COR Analyzer(TM) performs analysis of Coronary CT angiography (CCTA) studies and automatically without human intervention identifies severe lesions in the main coronaries. The COR Analyzer(TM) is aimed at triaging patients in the ED, improving workflow in the radiology and cardiology departments and serving as 'second eye reader' to prevent miss-reading of severe lesions in CCTA studies. (www.rcadia.com)

About BioVentures Investors

BioVentures Investors, based in Cambridge, Massachusetts, has three venture funds focused on the commercial development of advanced technology in life sciences and healthcare. The three general partners have all been CEOs of companies active in the life sciences and healthcare industry. BioVentures currently has over $145 million under management. (www.bioventuresinvestors.com)

About 20/20 HealthCare Partners

20/20 HealthCare Partners LLC (20/20HCP) is a Boston-based partnership providing management services and equity financing for medical device companies with promising growth potential. 20/20HCP's unique focus is on diagnostic imaging and diagnostic image enhancement applications as well as on the evolution of diagnostic imaging in personalized medicine. 20/20HCP establishes a structure and strategic partnerships for the early identification of opportunities, as well as expedites opportunity development through nimble management and short product development cycles. (www.2020hcp.com)


'/>"/>
SOURCE Rcadia Medical Imaging, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders
2. New research provides dynamic visualization of simplest circadian clock
3. New approach sheds light on ways Circadian disruption affects human health
4. Circadian Rhythm Plays Role in Memory
5. Dont Disturb Your Circadian Rhythm This Black Friday Sleep In, Nap Later, says Specialty Sleep Association
6. MSU engineering team designs innovative medical device
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
9. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
10. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
11. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: